Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Co-Aprovel- HCP letter- Hydrochlorothiazide and the risk of non-melanoma skin cancer

For Hard copies of this information booklet please contact Sanofi medical information department on 0845 372 7101 or email [email protected]

For Healthcare Professionals

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.